Physician profile
Sarah Daoud
NPI 1346095171
$2,360.25
in general payments reported to CMS, 2019-2025
18 companies · $1,784 in 2025
The $1,784 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $577 · 2025: $1,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,360.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.81 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $252.85 | 2024-2025 | |
| Amgen INC. | $193.65 | 2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $188.64 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $142.90 | 2025 | Zoryve |
| Ucb, INC. | $127.50 | 2025 | Bimzelx |
| Dermavant Sciences, INC. | $124.98 | 2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $122.58 | 2024 | Cabtreo |
| Janssen Biotech, INC. | $103.72 | 2025 | Tremfya, Simponi, Simponi Aria |
| Mayne Pharma Commercial LLC | $85.27 | 2025 | |
| Incyte Corporation | $85.05 | 2024-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $72.55 | 2025 | Dupixent |
| Genzyme Corporation | $69.77 | 2025 | |
| Novartis Pharmaceuticals Corporation | $69.69 | 2025 | |
| Botanix Sb INC | $37.73 | 2025 | Sofdra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $18.44 | 2025 | Veregen |
| Journey Medical Corporation | $16.61 | 2025 | |
| Organon LLC | $9.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Daoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.